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Summary 
Mixed xenogeneic bone marrow reconstitution (mouse +  rat -~ mouse) results in stable mixed 
lymphopoietic chimerism (1-48% rat), long-term survival, and the induction of stable functional 
donor-specific transplantation tolerance to xenoantigens in vivo. To examine the role of negative 
selection of potentially xenoreactive T  lymphocytes during tolerance induction across a species 
barrier, mixed xenogeneic chimeras (mouse +  rat -~ mouse) were prepared and analyzed using 
a mixture of mouse and rat bone marrow cells for relative T cell receptor (TCR)-Vfl expression 
on mouse T cells. In mixed xenogeneic chimeras (B10 mouse +  rat --~ B10 mouse), T cell maturation 
proceeded normally in the presence of rat bone marrow-derived elements, and functional donor- 
specific tolerance to rat xenoantigens was present when assessed by mixed lymphocyte reactivity 
in vitro. Vfl5, which is expressed at high (undeleted) levels in normal B10 mice, was consistently 
deleted in B10 recipients of Wistar Furth (WF), but not F344 rat bone marrow, whereas the 
coadministration of either F344 rat or WF rat bone marrow with B10 mouse bone marrow 
cells resulted in a significant decrease in expression of TCR-Vf111. Taken together,  these data 
demonstrate for the first time that rat bone marrow-derived cells can contribute in a strain- 
specific manner to the ligand for negative selection of specific mouse TCR-VB during tolerance 
induction across a species barrier. 
p rogress in clinical organ transplantation has resulted in 
a critical shortage of solid organ allografts (1). Xenotran- 
splantation has been suggested as a potential solution to this 
problem. However, traditional immunosuppressive agents that 
control rejection of allografts  have not been  successful in 
prevention of rejection of xenografts (2). The induction of 
tolerance to ~enoantigens has been suggested as one method 
to overcome these limitations. We recently developed a model 
to induce stable donor-specific transplantation tolerance for 
a closely related species combination (mouse +  rat -~ mouse) 
(3).  Recipients engrafted with rat bone marrow stem cells 
exhibited excellent survival and specifically accepted donor- 
strain skin xenografts but rejected MHC-disparate third-party 
grafts (3, 4). Development of rat-derived T  lymphocytes in 
the mouse recipients proceeded in a normal phenotypic fashion 
when analyzed by flow cytometry (3). We have now applied 
this model to examine whether negative selection of poten- 
tiaUy xenoreactive T  lymphocytes can be identified during 
tolerance induction across a species barrier. 
The mature TCK repertoire has been shown to be the re- 
sult of both positive and negative selection events that occur 
in the thymus during development. It is currently believed 
that a precursor T cell entering the thymus will undergo one 
of three developmental fates.  If the developing T  cell does 
not recognize any components of the thymic environment, 
it will die by programmed cell death (5, 6). If the TCK in- 
teracts  with  MHC  molecules (or MHC  plus peptide)  on 
thymic epithelial cells, positive selection occurs with matu- 
ration into a functionally mature T  cell (6-11).  Interaction 
of the TCR with bone marrow-derived elements such as mac- 
rophages or dendritic cells may result in negative selection 
(donal deletion) of potentially self-reactive lymphocytes (6, 
12-16). These selection events with the thymus are believed 
to shape the final TCR repertoire, with the final result that 
self-antigens are not recognized by mature T  cells and for- 
eign antigenic peptides are recognized only in association with 
self-MHC (16,  17). In addition to this intrathymic pathway 
for T  cell repertoire selection, it has recently been demon- 
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cally (18, 19). 
The functional elimination of potentially self-reactive lym- 
phoid cells through clonal deletion was first  postulated by 
Burnet more than thirty years ago (17). mAbs specific for 
the/3 chain of individual TCR-cr  VB gene products, as 
well as molecular probes for gene expression,  have recently 
been utilized to demonstrate the negative selection of TCR- 
V~ reactive to endogenous ligands during T cell repertoire 
generation (12-29).  These deletions appear to occur during 
T  cell  development at  the double-positive (CD4+CD8 +) 
stage of intermediate maturity (15, 30). TCR-V/3-specific de- 
letions have been identified that correspond to elimination 
of T cells reactive to endogenous mouse superantigens such 
as minor lymphocyte stimulatory (Mls) ~ antigens in associ- 
ation with self-MHC products (12, 14, 16, 23, 24, 26-29). 
Similar TCR-specific deletion was observed in transgenic mice 
expressing TCR-od~8 specific for other endogenous antigens 
such as HY (31-34).  However, Mls and HY are only very 
weak transplantation antigens (35-40) and how these mech- 
anisms for deletion of potentially self-reactive T  cells relate 
to the induction of donor-specific  tolerance for class I and 
class II transplantation alloantigens has not yet been fully 
defined. 
We  recently  reported  the  induction  of  stable  mixed 
xenogeneic (mouse  +  rat ~  mouse) chimerism achieved when 
untreated rat bone marrow was transplanted into lethally ir- 
radiated  B10  mouse  recipients  (3,  4).  Recipients  were 
specifically tolerant to donor-strain rat skin grafts, yet were 
competent to reject MHC-disparate third-party rat and mouse 
skin grafts. In the present studies we have investigated the 
role of negative selection in the induction and maintenance 
of donor-specific  transplantation tolerance to xenoantigens. 
We have examined whether negative selection of potentially 
self-reactive TCR-V/3 could occur in the presence ofxenogeneic 
bone marrow-derived cells by examining whether a detect- 
able deletion in the mouse T cell repertoire occurs in the pres- 
ence of  rat xenoantigens. In mixed xenogeneic chimeras (mouse 
+  rat ~  mouse), a selective deletion of V~5-positive mouse 
T cells was observed when a WF rat was the xenogeneic donor 
(B10 mouse +  WF rat ~  B10 mouse), but not in B10 mouse 
+  F344 rat ~  B10 mouse chimeras.  Similarly,  significant 
deletion of V/3-11-positive TCR occurred when a WF rat, 
or F344 rat bone marrow, were coadministered with B10 
mouse bone marrow into B10 mouse recipients.  These data 
demonstrate that xenoantigens can contribute in a strain- 
specific manner to the ligand for mouse TCR-VB-specific de- 
letion during tolerance induction across a species barrier. 
Materials  and Methods 
Animals.  6-8-wk-old male C57BL/10SnJ (B10), B10.BR./SgSn 
(B10.BR.), BALB/c mice were purchased from The Jackson Labo- 
ratory (Bar Harbor, ME). 4-8-wk-old  male Fischer  344 (1:344), ACI, 
1  Abbreviations used in this paper: Mls, minor  lymphocyte  stimulatory;  MST, 
median survival time. 
and Wistar Furth (WF) male rats were purchased from Harlan 
Sprague Dawley, Inc. (Indianapolis, IN). Animals were housed in 
a specific pathogen-free facility at the Biomedical Science Tower 
at the University of Pittsburgh. 
Mixed Xenogeneic Bone Marrow Reconstitution (Mouse +  Rat --~ 
Mouse).  Mixed  xenogeneically  reconstituted  animals  were prepared 
by a modification of the method previously described for prepara- 
tion of  mixed allogeneic  chimeras 0, 4). Briefly,  inbred C57BL/10Sn 
male recipients were lethally irradiated with a single dose of 950 
rad from a Cesium source (Nordion, Ontario, Canada). Using sterile 
technique, bone marrow was flushed with Medium 199 (Gibco 
Laboratories, Grand Island, NY) containing 50/~l/ml gentamicin 
from the femurs and tibias of mice and rat donors with a 22-gauge 
needle. This medium mixture will hence be referred to as MEM. 
The marrow was mechanically  resuspended  in MEM by gentle aspi- 
ration  through an  18-gauge needle and the  suspension filtered 
through sterile nylon mesh. The cells were then pelleted at 1,000 
rpm for 10 min, resuspended, and counted. B10 or B10.BR bone 
marrow cells were T cell depleted by treatment with a 1--40 dilu- 
tion of rabbit anti-mouse brain serum in MEM (10  s cells/ml) (4~ 
for 30 min) plus guinea pig complement (37~  for 30 min) (Gibco 
Laboratories) as previously  described (3, 4). Cells were washed  twice 
and resuspended  in MEM at the appropriate  concentration to allow 
injection of 1 ml per animal. Recipient animals were reconstituted 
within 4-6 h after irradiation via the lateral tail veins using a 27- 
gauge needle. 
Mixed Xenogeneically Reconstituted Animals.  These  animals re- 
ceived 5  x  10  ~ T ceLl-depleted  bone marrow cells plus 4  x  107 
untreated rat bone marrow cells unless otherwise specified. Under 
these conditions it has been demonstrated that the majority of T 
lymphocytes  in these animals  are derived  from the rat bone marrow 
stem cell precursors and not contaminating T lymphocytes in the 
bone marrow inoculum, since T cell maturation proceeds in a de- 
velopmentally  regulated fashion in the thymus (3). Radiation con- 
trols were prepared to confirm adequacy of the radiation. 
Characterization of Chimeras by Flow Cytometry.  Recipients  were 
characterized for engraftment with syngeneic and/or xenogeneic 
donor lymphoid elements using flow cytometry to determine the 
percentage of PBL bearing H-2  b or H-2  ~ and F344, WF, or ACI 
surface markers (3). Briefly, peripheral blood was collected into 
heparinized plastic serum vials. After thorough mixing, the sus- 
pension was layered  over 1.5 ml of room temperature lymphocyte 
separation medium (LSM) (Organon Technica, Kensington, MD) 
and centrifuged at 23~  (1,700 rpm for 30 min). The lymphocyte 
layer was aspirated from the saline-LSM  interface and washed with 
medium. Red blood cells were ACK lysed (ammonium chloride 
potassium carbonate lysing buffer; made in our laboratory) and the 
remaining cells stained with appropriate mAbs for 30 rain at 4~ 
and counterstained with sandwich when required. 
Analyses of sl?lenic  and thymic lymphoid cells were performed 
using a FACS  II  |  (Becton Dickinson & Co., Mountain View, CA) 
as previously described 0). mAbs anti-WF and anti-F344-Biotin, 
which were generated in rats and generously  supplied  by Dr. Heinz 
W. Kunz (University  of  Pittsburgh), were utilized  for class I staining 
of rat calls (3). Anti-H-2  b mAb 28-8-6S (IgG2a; HB31; American 
Type Culture Collection, Rockville,  MD) (characterized  in our lab- 
oratory) was utilized for anti-H2  b staining. Anti-CD4-PE mouse 
(Becton Dickinson & Co.), anti-Thy-l.2-PE (Becton Dickinson & 
Co.), anti-CD8-FITC mouse (Becton Dickinson & Co.), and anti- 
TCR-ce/B FITC (Pharmangen, San Diego, CA) were utilized for 
cellular subset staining. Data were displayed  as cell frequency  histo- 
grams in which log fluorescence  intensity was displayed on the 
horizontal axis and relative cell number of the vertical axis. The 
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vant mAb was calculated using a cut-off for Positivity determined 
from the control fluorescence  profiles of negative and positive con- 
trol popuhtions (B10 mouse and F344 rat). 
Two-color Flow Cytometry Analysis Of Relative TCR-V[$ Expres- 
sion.  Spleen  ceils from normal or chimeric animals were enriched 
for T cells by passing over rabbit anti-mouse Ig-coated plates. 106 
T-enriched spleen cells were stained as previously described (12). 
Antibodies used in the study were oN/33, KJ25 (41), ctV/35, MKg.4 
(42), dr  KK4-7 (43), oN/37, TK-310 (44), oN/38, F23.1 (45), 
dr  MK10.2 (46), c/r  KK3-15 (47), oN/~13, MK12.4 (48). 
The students t test was utilized to analyze significance estimates. 
Mixed Lymphocyte Culture Cellular Proliferative Assay (MLR). 
Xenogeneic MLK were performed by a modification of that previ- 
ously described by Hoffman et al. (50) for allogeneic  MLK. Briefly, 
murine sphnocytes and rat lymph nodes were made into single cell 
suspensions, ACK-lysed (prepared in our laboratory), washed, and 
reconstituted in DMEM (Gibco Laboratories) supplemented with 
a 0.75% normal mouse serum, 0.09 mM nonessential amino acids, 
1 mM sodium pyruvate, 2 mM glutamine,  100 U/m1 penidllin, 
100 #g/ml streptomycin, 0.05 mM 2-ME, and 1 mM N~-mono  - 
methyl L-arginine (50). 4  x  105 responding lymphocytes were 
cocultured with 4  x  10  ~  irradiated stimulator lymphocytes (2,000 
tad) in a total of 200 #1 of media. Cultures were incubated at 37~ 
10% CO2 for 4 d, pulsed on the third day with 1 #Ci [3H]thymi- 
dine (New England Nuclear, Boston, MA), and harvested on the 
fourth day with an automated harvester (PHD Cell Harvester; Tech- 
nology, Inc., Cambridge, MA). 
Results 
Typing of Mixed Xenogeneically Reconstituted (Mouse + Rat 
-* Mouse) Mice:. Documentation oJ Xenogeneic Lymphoid Chimer- 
/sin.  To determine whether negative sdection of potentially 
xenoreactive mouse T  lymphocytes would occur as a result 
of tolerance induction across a species disparity, mixed xeno- 
geneic chimeras were prepared and typed for rat and mouse 
lymphoid chimerism 28 d after reconstitution using anti-F344 
(KtlA1), or anti-WF (KtlA  u) class I and anti-H-2  b mAbs. 
As in our previous experience, rat lymphoid chimerism was 
reliably present in all mixed xenogeneic chimeras and ranged 
from 1% to 46%  (data not shown). To maximize the per- 
centage of rat xenoantigens present, chimeras with a high 
percentage (>5%) of rat lymphoid chimerism were chosen 
for analysis  of mouse Thy-l.2 + TCK-Vfl expression.  B10 
mice were reconstituted with a mixture of B10 mouse plus 
rat bone marrow using ACI, F344, or WF rat as the xeno- 
geneic donors (i.e.,  B10 mouse +  F344 rat --* mouse). As 
previously described, B10 mice do not normally delete any 
of the characterized TCK-V/g while the congenic B10.BK 
strain reliably deletes V35, -11, -12, and -16 (29).  Chimeras 
prepared with B10 mouse as the syngeneic donor and recip- 
ient would therefore serve to detect any potential deletions 
in mouse TCK repertoire resulting from contribution of the 
rat bone marrow-derived ceils to the ligand for TCK-V3 rec- 
ognition during T ceil development and tolerance induction. 
Maturation Of Mouse T Lyraphocytes in Thymus Of Mixed 
Xenogeneic Chimeras.  T  cell maturation has been demon- 
strated to occur in the thymus through interaction with the 
thymic stroma and bone marrow-derived connective tissues 
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(6-17). We have now examined the staining profile of mouse- 
derived lymphoid ceils in the thymus and spleen of mixed 
xenogeneic chimeras to determine whether the developmen- 
tally regulated expression of CD4, CD8, CD3, and TCR-ol/3 
antigens would occur normally in the thymus and periphery. 
The expected populations of mouse TCR-cc/3-negative, dull, 
and bright populations and CD4- CD8 -, CD4 +  CD8 +, and 
CD4 +  CD8-  or CD4-CD8 + cells were present in thymus 
of all chimeras analyzed (Fig.  I A), while mature, single- 
positive TCR-cd/3bng ht, CD4-CD8 + or CD4+CD8 -  cells 
were  observed  in  splenic  Thy-l.2 +  lymphoid  cells  from 
chimeras (Fig. 1 B). The apparent increase in Thy-l.2-negative 
cells and in mouse CD4- and CD8-negative markers in thymus 
of the mixed xenogeneic chimeras is due to the presence of 
rat lymphocytes that were not stained by these species-specific 
reagents directed against mouse lymphocytes (3). The profile 
for T  cell staining resembled that  for normal B10  mouse 
thymus and spleen. 
Evidence  for In Vitro Functional Tolerance  in Mixed Xenogeneic 
Chimeras.  We have previously demonstrated that  donor- 
specific rat skin xenografts were significantly prolonged (me- 
dian survival time [MST]  >180  d) while MHC-disparate 
third-party mouse and rat grafts were promptly rejected (MST 
--  10 and 20 d, respectively) by mixed xenogeneic (B10  + 
[F344 or WF] ~  B10) chimeras (3, 4), We have now exam- 
ined splenic lymphoid ceils from these recipients in vitro using 
mixed lymphocyte culture proliferative (MLR) assays for evi- 
dence of functional tolerance to donor and reactivity to third- 
party xeno and aUoantigens. As seen in a representative MLK 
(Table  1), mixed xenogeneic chimeras exhibited functional 
tolerance to both host and donor xenoantigens, while their 
responses to MHC-disparate third-party rat or mouse stimu- 
lator ceUs were intact, demonstrating the presence of specific 
functional tolerance to donor xenoantigens. 
Analysis of TCR-V(3 Expression in Mixed Xenogeneic Chimeras 
(1310  +  Rat --~ BIO).  The VB-specific deletion of T  cells 
specific for endogenous antigens (superantigens) has to date 
been demonstrated only in the mouse (49).  To determine 
whether bone marrow-derived rat cells can contribute to the 
ligands that mediate V/3-spedfic deletion, chimeras were pre- 
pared (B10 mouse  +  F344 rat ~  mouse, and B10 mouse 
+  WF rat ~  B10 mouse) and typed for chimerism 28 d 
after reconstitution (Table 2). B10 mice have been shown to 
be permissive for expression of V/~2, -3, -5, -6, -8, -9, -11, 
-13, and -14, and were therefore utilized as recipients to de- 
tect any potential deletions in repertoire that may have resulted 
due to the presence of additional ligands provided by rat bone 
marrow-derived ceils. Those animals with the highest level 
of rat lymphoid chimerism (>5%) were again sdected for 
analysis  of mouse Thy-l.2 +  TCK-V/~  expression.  In  B10 
mouse +  F344 rat ~  B10 mouse chimeras, no deletions were 
identified for TCK-V~2, -3, -5, -6, -8, -9, -13, or -14 expres- 
sion (Table 2, and data not shown). In B10 mouse  +  WF 
rat ~  B10 mouse chimeras, no deletions were identified for 
TCK-VB3, -6, -8, -9, -13, or 14. In striking contrast, V~5- 
TCK expression was significandy reduced to levels similar 
to normal B10.BK mice (a V/~5 deleting strain) in all mixed 
xenogeneic (B10  +  WF --~ B10) chimeras (p  -- 0.004), but A 
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Figure  1.  (A)  Flow cytometry 
analysis of mouse CD4, CD8, Thy- 
1.2, and TCR-(x/~ determinants on 
T  lymphocytes  in thymus of un- 
manipulated B10 mouse and mixed 
xenogeneic chimera (B10 mouse + 
ACI rat ~  B10 mouse) 8 wk after 
reconstitution.  Total rat lymphoid 
chimerism in the chimera was 48%. 
Directly labeled antibody  was uti- 
lized and unfractionated thymocytes 
were  analyzed.  Leu-4-FITC  and 
Leu-4-PE were used as the fluores- 
cent controls. All antibodies utilized 
were not crossreactive on rat lym- 
phoid  cells. (B)  Flow  cytometry 
analysis of mouse CD4, CD8, Thy- 
1.2, and TCR-(x/B determinants on 
T lymphocytes  in spleen of mixed 
xenogeneic chimera (B10 mouse + 
F344  ~  B10  mouse)  8  wk  after 
reconstitution.  Directly labeled an- 
tibody was utilized and unfractio- 
nated  splenocytes  were  analyzed. 
The animal is the same as that for A. 
not in B10 mouse +  F344 rat --~ mouse chimeras (p := 0.56) 
(Table 2). A representative flow cytometry staining pattern 
is shown in Fig. 2. Decreases in mouse TCR-Vf111 expres- 
sion were also observed when either F344 rat ~  < 0.04 com- 
pared with normal B10 mice) or WF rat ~  <  0.002) were 
the xenogeneic donor, although the level of deletion was not 
as complete as that observed in syngeneically reconstituted 
B10.BR ~  B10.BR recipients (Fig.  3). These data suggest 
that rat bone marrow-derived cells can contribute in a strain- 
specific manner to the ligand for negative selection of selected 
mouse TCR-Vfl in mouse chimeras rendered tolerant to rat 
xenogeneic antigens. 
Discussion 
It has been demonstrated that during intrathymic T  cell 
development, negative selection or clonal deletion occurs, 
resulting in the elimination of those maturing T  cells that 
express potentially self-reactive TCR. A similar process can 
occur in peripheral T  cells (18,  19). In the mouse, a set of 
endogenous or self-antigens exists that has the property, when 
presented in  association with  a  permissive MHC  class II 
product, of interacting with all or nearly all T cells that ex- 
press a given TCR-Vfl product.  As a correlate of this VB 
specificity,  mice expressing an endogenous antigen of this 
sort in association with a permissive class II product will de- 
lete most or all  T  cells expressing the corresponding VB 
product. These TCR-VB ligands have been termed superan- 
tigens and recent reports have indicated that the superantigen 
ligands characterized to date, including the ligands for VB3, 
-5, -6, -8.1,  -9, and -11, are endogenous mouse mammary 
tumor virus products (48,  49).  To date, VB-specific clonal 
deletion has not been demonstrated to occur in species other 
than the mouse. It thus remains to be determined whether 
the  existence of VB-specific  endogenous  superantigens  is 
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[3H]Thymidine incorporation 
Responding animal  Anti-B10  Anti-F344  Anti-BALB/c  Anti-ACI  Anti-self 
cpm  +_  SEM 
Normal B10  2,891  +_  177"  18,143  •  5,225  23,416  •  837  54,673  •  8,215 
Normal F344  38,703  •  7,278  1,319  •  107  27,181  _+ 4,925  38,899  _+ 8,215 
B10 + F344---~B10 
chimera  no.  1  5,503  •  1,044  2,338  _+  194  36,842  +  377  40,862  •  4,210 
B10 + F344 ~  B10 
chimera  no.  2  4,682  •  299  2,349  _+ 56  63,307  +  9,773  33,269  _+ 8,781 
5,423  +  450 
4,569  _+ 393 
Stimulation  index 
B10  F344  BALB/c  ACI 
B10  1.0  6.3  8.0  18.9 
F344  29.0  1.0  20.6  29.5 
Chimera  no.  1  1.0  0.4  6.8  7.5 
Chimera  no.  2  1.0  0.5  13.9  7.3 
* Mean _+ SEM of triplicate cultures in 1:1 responder-to-stimulator ratio. Animals were tested 5 mo after reconstitution. This is one representative 
of four experiments. 
unique to the mouse, or is generalized to other species.  In 
addition, superantigens such as Mls function poorly, if at all, 
as transplantation alloantigens (35, 36). In general, rejection 
of tissue grafts involving an isolated minor antigen disparity 
has been demonstrated to occur in a fashion distinct  from 
responses to MHC-incompatible grafts in that they are rec- 
ognized only in an MHC-restricted fashion and do not re- 
suit in antibody production against the alloantigens (35-40). 
The role of specific clonal deletion in the induction of toler- 
ance to transplantation  alloantigens  has only recently been 
addressed (51,  52). 
There are obvious similarities  between the model for toler- 
ance to endogenous self-antigens and tolerance induced by 
allogeneic bone marrow transplantation  in the adult recip- 
ient, in which precursor cells enter the thymus where they 
are educated. The role of donal deletion in tolerance induc- 
tion of new self for recipients of bone marrow allografts has 
been recently evaluated in allogendc strain combinations using 
neonatal  and adult bone marrow  chimeras  (51-53).  In al- 
logeneic radiation chimeras,  the fate of potentially self-reactive 
T lymphocytes is largely determined by the derivation of bone 
marrow-derived stromal cells in the thymus (6, 13, 52-55). 
In fully allogeneic chimeras,  Roberts et al.  (14) and Rams- 
dell and Fowlkes (16) both demonstrated that clonal deletion 
of potentially autoreactive T lymphocytes in the thymus oc- 
curred if the appropriate donor bone marrow-derived stromal 
cells were present.  In their absence, functional inactivation 
or anergy resulted. In addition, it has been reported that the 
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fate of V/36 + T  cells  was determined  by the H-2 type of 
stem cells used for bone marrow reconstitution (39, 51). Speiser 
et  al.  (56)  demonstrated  that  in  radiation  chimeras  (Mls  ~ 
recipients)  reconstituted  with  bone  marrow  from  IE- 
donors,  substantial  numbers  of mature V/36 + T  cells that 
were functionally anergic to host Mls-l' in vitro were present 
in the peripheral  lymphoid tissues despite host Mls-l' ex- 
pression in vivo. In contrast, when an I-E + strain was used 
as the donor for bone marrow transplanted into an I-E- re- 
cipient, clonal deletion of potentially self-reactive T cells oc- 
curred (56). 
We have now examined whether similar deletion of poten- 
tially self-reactive T  cells could occur in chimeras  tolerant 
across xenogeneic disparities to determine whether negative 
selection could proceed normally in a xenogeneic environ- 
ment. We have also examined whether rat bone marrow-de- 
rived cells could contribute to ligands for deletion of mouse 
T cells during the induction of tolerance across a species bar- 
tier. The current report demonstrates for the first time that 
rat bone marrow-derived cells can contribute to the ligands 
for negative selection of mouse T cells expressing specific V/3s 
in chimeras rendered tolerant to rat xenoantigens (mouse + 
rat  ->  mouse). 
The V/3-specifir deletion ofT cells specific for endogenous 
antigens (superantigens) has to date been demonstrated only 
in the mouse. To determine whether bone marrow-derived 
rat cells can contribute to ligands that mediate VB-specific 
deletion during the induction  of tolerance across a species Table  2.  PBL  Typing and Relative  V~-TCR  Expression in Mixed Xenogeneic  Chimeras (Mouse  4-  Rat -~ Mouse) 
PBL typing of chimeras  Relative TCR-VB antigen expression 
Animal 
Reconstitution  no.  Percent rat  Percent mouse  5  6  8  11 
B10 + F344---~B10  912  16.8  86.1  5.4  2.6  19.9  4.9 
916  31.0  78.0  5.3  7.3  6.6  5.0 
410  19.2  80.1  3.9  8.3  19.1  1.4 
992  20.3  78.8  0.4  9.0  18.2  0.5 
913  22.6  81.5  5.8  6.0  8.6  3.6 
668  21.0  80.0  6.8  6.0  21.6  4.4 
670  16.5  84.4  7.5  8.9  21.5  5.9 
409  11.2  89.8  2.5  7.0  20.4  1.0 
B10 + WF-~B10  935  29.0  69.5  0  9.5  24.8  2.1 
862  15.0  86.0  1.1  8.9  24.8  0.9 
710  12.2  88.0  1.2  7.8  27.1  2.9 
708  21.0  79.2  2.4  7.3  26.0  5.7 
936  45.0  64.0  0.8  8.9  12.4  3.3 
716  6.2  94.2  1.2  8.5  22.1  0.6 
717  5.7  95.3  1.7  7.4  27.0  0.6 
718  6.8  94.6  1.2  8.8  22.0  0.7 
BR-~BR  863  0.1  99.0  0.8  8.8  22.5  0.3 
864  0.2  99.6  0.3  10.1  20.3  0.2 
298  0  100.0  2.4  7.7  27.2  1.1 
Normal B10  -  4.4  6.3  18.1  4.8 
Thy-l.2 typing was performed on splenic lymphoid  cells at the time of VB-TCR expression analysis. Animals were between 5 and 10 wk after 
reconstitution at the time of V~-TCR analysis. 
barrier, mixed xenogeneic (mouse +  rat --* mouse) chimeras 
were prepared, and the fate of Thy-l.2 + mouse T  cells was 
examined.  Maturation  of mouse-derived  T  lymphocytes 
proceeded normally in the presence of rat-derived lymphoid 
cells in mixed xenogeneic chimeras (mouse +  rat ~  mouse). 
The mouse T lymphocytes from chimeras were functionally 
tolerant to donor-strain rat xenoantigens in vitro when ex- 
amined in MLR assays, yet responded to MHC-disparate third- 
party mouse and rat lymphoid cells, suggesting the presence 
of MHC-specific donor-specific transplantation tolerance for 
both mouse and rat antigens. 
When mixed xenogeneic chimeras were prepared using F344 
as the xenogeneic donor (B10 +  F344 --~ B10), no significant 
differences in expression of TCR-VB2, -3, -6, -8, -9, -13, or 
-14 were detected when compared with B10 mouse controls. 
The same was true when WF rat was the donor in mixed 
xenogeneic reconstitutions involving B10 mouse recipients. 
In striking contrast, VI35-TCR expression was significantly 
decreased  or  absent  in  all chimeras  examined when  WF 
(RtlA  u) (n  --  8; p  =  0.004)  was used as the xenogeneic 
donor, but not when F344 was used in the xenogeneic donor 
for this same recipient mouse strain (p  =  0.56).  Expression 
of VB11 was significantly depressed  when compared with 
normal B10 mice when F344 or WF rat bone marrow were 
coadministered with B10 mouse bone marrow. However, the 
level of deletion was not as complete as that observed for 
B10.BR -~ B10.BR syngeneically  reconstituted mice. These 
data therefore suggest that for selected strain combinations, 
the exogenous rat xenoantigens contributed at least a por- 
tion of a ligand causing VB-specific deletions during the in- 
duction of tolerance to rat xenoantigens in mixed xenogeneic 
chimeras.  In the mouse, the ligands for VB-specific T  cell 
depletion have been shown to require both MHC-encoded 
and non-MHC-encoded gene products.  Thus,  there are  a 
number of possible means by which rat gene products might 
contribute to the deletion of mouse T cells expressing specific 
Vfl products. The deletion of VB5-expressing  T cells in (B10 
mouse +  WF rat --~ B10 mouse) chimeras may be mediated 
by ligand consisting entirely of WF rat gene products; that 
is, VB5-expressing T cells may recognize xenoantigens specific 
for the WF rat. Alternatively, VB5-specific deletion may in- 
volve an interaction of mouse and rat products. For example, 
MHC class II products expressed  on rat bone marrow-de- 
rived cells may be capable of presenting a non-MHC-encoded 
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Figure 2.  Analysis of V3 expres- 
sion in representative mixed xeno- 
geneic  chimeras  (B10 mouse  + 
F344  rat  ~  B10  mouse  or  BIO 
mouse  +  WF rat  --~ B10 mouse) 
by  direct  immunofluorescence. 
Animals were compared with syn- 
geneically  (B10.BR  ~  B10.BR) 
reconstituted  mice. 106 T-enriched 
spleen cells were stained with anti- 
VB culture supernatant  and  goat 
anti-rat FITC followed by Thy-l.2 
biotin and texas-red avidin. Percen- 
tages indicate the number of Thy- 
1.2 +  cells  that  express  a  specific 
V/~ The percentage of cells staining 
with the control antibody has been 
subtracted. 
superantigen product of the B10 mouse. The fact that B10 
mice express the non-MHC component of the V35 ligand, 
but fail to express a permissive class II MHC product, is con- 
sistent with this possibility (29).  Attempts to identify the 
rat gene product that contributes to V35 deletion are cur- 
rently in progress using congenic strains of inbred rats. 
Theoretically, if a specifically xeno-reactive subset of re- 
cipient  T  lymphocytes  could  be  identified  (e.g.,  VB5 + 
T cells), one might predict that in vivo depletion of this subset 
of T lymphocytes in B10 mouse recipients might allow a fo- 
cused method to induce transplantation tolerance or hyporeac- 
tivity to xenoantigens utilizing a relatively benign but specific 
approach during tolerance induction across a species barrier. 
Studies are planned to evaluate in vivo depletion of V35 + 
and/or  V311 +  T  cells  in  B10  mice before bone marrow 
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Figure 3.  TCR-VB exT~ssion in chimeric animals. Mean •  SEM specific 
TCR=V33, -5, -6, and -11 expression in mixed xenogeneic chimeras, B10 
mice,  and BI0.BR ~  B10.BR. reconstituted  mice. 
reconstitution to determine whether facilitated rat stem cell 
engraftment will occur using a nonlethal conditioning ap- 
proach. 
It has been suggested that at least one of the ligands for 
VB5 and V311 deletion is the same, based upon similar strain 
distributions (25,  57,  58).  Quantitative differences in V35 
and %811 expression have been reported, however, in some 
mouse  strains  (25,  57,  58).  Our  present  data  in  mixed 
xenogeneic chimeras are consistent with these findings, since 
V35 was consistently deleted in all recipients, whereas V311 
deletion was less complete. Thus, qualitative or quantitative 
differences appear to exist in negative selection of V35- and 
V/~ll-expressing T cells. Studies are now in progress to evaluate 
whether these potentially autoreactive V~11 TCR + T cells 
in the periphery of mixed xenogeneic chimeras (mouse  + 
rat --~ mouse) are functional or anergic. It is of note that 
there is no evidence for GVHD in the chimeras and survival 
is excellent (3), supporting the concept that although present, 
these potentially autoreactive TCR-V311 + cells may not be 
functional. 
In summary, we demonstrate for the first time that nega- 
tive selection of selected mouse TCR-V3 can occur across 
a closely related species barrier during the induction of toler- 
ance  to  transplantation  xenoantigens.  Mixed  xenogeneic 
chimeras exhibited functional tolerance in vitro to donor- 
specific rat xenoantigens yet were competent to respond to 
MHC-disparate third-party rat xenoantigens. We have iden- 
tiffed that rat bone marrow-derived cells can contribute to 
the ligand for negative selection of specific mouse TCR-V3 
in  mixed xenogeneic (mouse  +  rat  ~  mouse) chimeras. 
Studies are in progress to examine the role of these specific 
TCR-V3 in transplantation tolerance to xenoantigens. 
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